Lung cancer patients may not need to wait till their radiation treatment is over to know if it worked. A PET scan several weeks after starting radiation treatment for lung cancer can indicate whether the tumor will respond to the treatment, according to a new study by researchers at the University of Michigan Comprehensive Cancer Center.
An enzyme that cancer cells eliminate, apparently so they can keep proliferating, may hold clues to more targeted, effective cancer treatment, scientists say.
Combining pre-operative chemotherapy and surgery increases the average chance of survival at five years by approximately 6 percent compared with surgery alone.
An analysis based on computerized simulation models suggests that the lifetime risk of cancer associated with radiation exposure from a computed tomography (CT scan) coronary angiography varies widely, with the risk greater for women and younger patients, according to a study in the July 18 issue of JAMA.
Eating a diet very high in vegetables, fruit and fiber and low in fat did not reduce breast cancer recurrence or death in early stage breast cancer survivors, according to a new study.
Women with early stage breast cancer who adopted a diet very high in vegetables, fruit and fiber and low in fat did not have a lower risk of breast cancer recurrence compared to women who followed a diet of five or more servings a day of fruit and vegetables (the ?5-A-Day? diet), according to a study in the July 18 issue of JAMA.
Researchers at the University of Pennsylvania School of Medicine identified a combination therapy as a way to sensitize resistant human cancer cells to a treatment currently being tested in clinical trials.
The U.S. Food and Drug Administration approved the first molecular-based laboratory test for detecting whether breast cancer has spread (metastasized) to nearby lymph nodes.
A tumor paint developed by researchers at Seattle Children?s Hospital Research Institute and Fred Hutchinson Cancer Research Center will help surgeons see where a tumor begins and ends more precisely by illuminating the cancerous cells.
By bypassing a well-known gene implicated in almost one-third of all cancers and instead focusing on the protein activated by the gene, Duke University Medical Center researchers believe they may have found a new target for anti-cancer drugs.